Your browser doesn't support javascript.
loading
Towards Reverse Vaccinology for Bovine TB: High Throughput Expression of Full Length Recombinant Mycobacterium bovis Proteins.
Paliwal, Deepa; Thom, Michelle; Hussein, Areej; Ravishankar, Divyashree; Wilkes, Alex; Charleston, Bryan; Jones, Ian M.
Afiliación
  • Paliwal D; School of Biological Sciences, University of Reading, Reading, United Kingdom.
  • Thom M; The Pirbright Institute, Woking, United Kingdom.
  • Hussein A; School of Biological Sciences, University of Reading, Reading, United Kingdom.
  • Ravishankar D; School of Biological Sciences, University of Reading, Reading, United Kingdom.
  • Wilkes A; School of Biological Sciences, University of Reading, Reading, United Kingdom.
  • Charleston B; The Pirbright Institute, Woking, United Kingdom.
  • Jones IM; School of Biological Sciences, University of Reading, Reading, United Kingdom.
Front Mol Biosci ; 9: 889667, 2022.
Article en En | MEDLINE | ID: mdl-36032666
ABSTRACT
Bovine tuberculosis caused by Mycobacterium bovis, is a significant global pathogen causing economic loss in livestock and zoonotic TB in man. Several vaccine approaches are in development including reverse vaccinology which uses an unbiased approach to select open reading frames (ORF) of potential vaccine candidates, produce them as recombinant proteins and assesses their immunogenicity by direct immunization. To provide feasibility data for this approach we have cloned and expressed 123 ORFs from the M. bovis genome, using a mixture of E. coli and insect cell expression. We used a concatenated open reading frames design to reduce the number of clones required and single chain fusion proteins for protein pairs known to interact, such as the members of the PPE-PE family. Over 60% of clones showed soluble expression in one or the other host and most allowed rapid purification of the tagged bTB protein from the host cell background. The catalogue of recombinant proteins represents a resource that may be suitable for test immunisations in the development of an effective bTB vaccine.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Mol Biosci Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Mol Biosci Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido